Market overview
The global contract research organization market is worth USD 91.8 bn in 2026 and is forecast to reach USD 198 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Clinical development is the largest by service segment.
| Scope | Outsourced research services sold to pharmaceutical, biotechnology and device sponsors, covering clinical trial management, preclinical and laboratory research, data management and regulatory services. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 85.0 bn |
| Value 2026 | USD 91.8 bn |
| Value 2036 | USD 198 bn |
| CAGR 2026-2036 | 8.0% |
| Volume 2026 | 47.4 thousand studies |
| Volume 2036 | 80.0 thousand studies |
| Average price 2026 | USD 1,936,000 per studie |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Contract Research Organization market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 91.8 bn |
| 2027 | USD 99.1 bn |
| 2028 | USD 107 bn |
| 2029 | USD 116 bn |
| 2030 | USD 125 bn |
| 2031 | USD 135 bn |
| 2032 | USD 146 bn |
| 2033 | USD 157 bn |
| 2034 | USD 170 bn |
| 2035 | USD 184 bn |
| 2036 | USD 198 bn |
Contract Research Organization market segmentation
By service
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Clinical development | 62.0% | 61.6% | USD 56.9 bn | 7.9% |
| Preclinical and discovery | 20.0% | 21.8% | USD 18.4 bn | 8.9% |
| Laboratory and central lab | 10.0% | 9.1% | USD 9.2 bn | 6.9% |
| Regulatory, safety and consulting | 8.0% | 7.6% | USD 7.3 bn | 7.4% |
By end user
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharmaceutical | 58.0% | 54.5% | USD 53.2 bn | 7.3% |
| Biotechnology | 34.0% | 38.4% | USD 31.2 bn | 9.3% |
| Medical devices | 8.0% | 7.2% | USD 7.3 bn | 6.8% |
By therapeutic area
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Oncology | 36.0% | 38.0% | USD 33.0 bn | 8.6% |
| Neurology | 14.0% | 14.0% | USD 12.9 bn | 8.0% |
| Cardiovascular | 12.0% | 11.0% | USD 11.0 bn | 7.1% |
| Infectious disease | 12.0% | 12.0% | USD 11.0 bn | 8.0% |
| Others areas | 26.0% | 25.0% | USD 23.9 bn | 7.6% |
By phase
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Phase I | 14.0% | 14.0% | USD 12.9 bn | 8.0% |
| Phase II | 26.0% | 26.0% | USD 23.9 bn | 8.0% |
| Phase III | 48.0% | 47.0% | USD 44.1 bn | 7.8% |
| Phase IV | 12.0% | 13.0% | USD 11.0 bn | 8.9% |
By sourcing model
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Full service | 46.0% | 42.0% | USD 42.2 bn | 7.0% |
| Functional service provider | 34.0% | 38.0% | USD 31.2 bn | 9.2% |
| Hybrid | 20.0% | 20.0% | USD 18.4 bn | 8.0% |
Top 25 countries for contract research organization by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.5% of 2026 revenue and the 25 countries below together hold 95.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 42.2 bn | 46.0% | USD 85.8 bn | 7.3% |
| 2 | China | USD 8.3 bn | 9.0% | USD 23.2 bn | 10.9% |
| 3 | United Kingdom | USD 5.5 bn | 6.0% | USD 11.3 bn | 7.5% |
| 4 | Germany | USD 4.6 bn | 5.0% | USD 9.3 bn | 7.3% |
| 5 | France | USD 3.7 bn | 4.0% | USD 7.5 bn | 7.5% |
| 6 | India | USD 3.7 bn | 4.0% | USD 11.3 bn | 11.9% |
| 7 | Japan | USD 3.2 bn | 3.5% | USD 6.1 bn | 6.7% |
| 8 | Switzerland | USD 2.8 bn | 3.0% | USD 5.5 bn | 7.3% |
| 9 | Spain | USD 2.3 bn | 2.5% | USD 5.0 bn | 8.0% |
| 10 | Canada | USD 2.3 bn | 2.5% | USD 5.0 bn | 8.0% |
| 11 | Netherlands | USD 1.5 bn | 1.6% | USD 3.1 bn | 7.5% |
| 12 | Belgium | USD 1.2 bn | 1.3% | USD 2.5 bn | 7.5% |
| 13 | Poland | USD 936 mn | 1.0% | USD 2.2 bn | 8.8% |
| 14 | Italy | USD 808 mn | 0.9% | USD 1.7 bn | 7.5% |
| 15 | Australia | USD 707 mn | 0.8% | USD 1.4 bn | 7.4% |
| 16 | Brazil | USD 698 mn | 0.8% | USD 1.6 bn | 8.7% |
| 17 | South Korea | USD 652 mn | 0.7% | USD 1.5 bn | 8.7% |
| 18 | Taiwan | USD 487 mn | 0.5% | USD 1.1 bn | 8.6% |
| 19 | Singapore | USD 450 mn | 0.5% | USD 1.0 bn | 8.6% |
| 20 | Sweden | USD 413 mn | 0.5% | USD 852 mn | 7.5% |
| 21 | Denmark | USD 303 mn | 0.3% | USD 634 mn | 7.7% |
| 22 | Mexico | USD 285 mn | 0.3% | USD 654 mn | 8.7% |
| 23 | Israel | USD 266 mn | 0.3% | USD 535 mn | 7.2% |
| 24 | Russia | USD 193 mn | 0.2% | USD 456 mn | 9.0% |
| 25 | Austria | USD 156 mn | 0.2% | USD 317 mn | 7.3% |
| Rest of world | USD 4.3 bn | 4.6% | USD 8.6 bn | 7.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- IQVIA
- Thermo Fisher Scientific (PPD)
- ICON
- Parexel
- Syneos Health
- Charles River Laboratories
Group 2: Regional and specialist players
- Medpace
- Fortrea
- WuXi AppTec
- Tigermed
- Labcorp Drug Development
- Eurofins
- Novotech
- PSI CRO
- Linical
- CMIC Holdings
Group 3: Emerging and niche players
- Allucent
- Premier Research
- Worldwide Clinical Trials
- Ergomed
- Avance Clinical
- Catalyst Clinical Research
- Caidya
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the contract research organization market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.
The market is divided by service, by end user, by therapeutic area, by phase, by sourcing model. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the contract research organization market?
The global contract research organization market is estimated at USD 85.0 bn in 2025 and USD 91.8 bn in 2026.
How fast will the contract research organization market grow?
It is forecast to reach USD 198 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 106 bn.
Which country is the largest market for contract research organization?
United States is the largest market by revenue at USD 42.2 bn in 2026, 46.0% of the global total. The three largest countries together hold 61.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 11.9% a year from 2026 to 2036.
Which contract research organization segment is largest?
In the by service split, Clinical development is the largest segment with 62.0% of 2026 revenue.
Who are the leading contract research organization companies?
Global leaders include IQVIA, Thermo Fisher Scientific (PPD), ICON, Parexel.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Generic InjectableUSD 93.3 bn · 6.3% CAGR
- Diabetes DrugsUSD 97.5 bn · 5.0% CAGR
- Cardiovascular DevicesUSD 83.8 bn · 7.0% CAGR
- TelemedicineUSD 103 bn · 13.0% CAGR
- VaccinesUSD 80.6 bn · 7.0% CAGR
- In Vitro DiagnosticsUSD 108 bn · 5.5% CAGR
- ImmunotherapyUSD 77.7 bn · 8.5% CAGR
- Peptide TherapeuticsUSD 110 bn · 12.0% CAGR
← Contract Development and Manufacturing Organization Cosmetic Peptide Manufacturing →